Parker Institute for Cancer Immunotherapy is a corporate venture arm. Based in San Francisco, California, United States. The known portfolio counts 8 companies, including ArsenalBio, Senti Biosciences, Azalea Therapeutics, Xaira Therapeutics, Georgiamune and Affini-T Therapeutics.
Is Parker Institute for Cancer Immunotherapy a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell and Gene TherapiesDiagnosticsDrug DiscoveryGenomicsImmunotherapy
Who to pitch at Parker Institute for Cancer Immunotherapy
Parker Institute for Cancer Immunotherapy portfolio companies (8)
- ArsenalBio
- Senti Biosciences
- Azalea Therapeutics
- Xaira Therapeutics
- Georgiamune
- Affini-T Therapeutics
- Dispatch Bio
- Akamis Bio
Co-investors
Funds that share portfolio companies with Parker Institute for Cancer Immunotherapy.
Similar funds
Showing 20 of 100
About Parker Institute for Cancer Immunotherapy
The firm's listing covers sector Healthcare, and focus areas Biotech, Cell and Gene Therapies, Diagnostics and Drug Discovery; known deals cluster at Growth, Late-Stage and Seed.
Sean Parker (Founder, Chairman) and Alice Lin Pomponio (Senior Vice President) are listed as the contacts to pitch at Parker Institute for Cancer Immunotherapy.
Parker Institute for Cancer Immunotherapy shares portfolio companies with 20 other investment firms, among them Byers Capital, Rock Springs Capital and University of Pennsylvania.
Frequently asked questions
What is Parker Institute for Cancer Immunotherapy?
Parker Institute for Cancer Immunotherapy is a corporate venture arm based in San Francisco, California, United States, with a known portfolio of 8 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Parker Institute for Cancer Immunotherapy invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell and Gene Therapies, Diagnostics and Drug Discovery. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does Parker Institute for Cancer Immunotherapy invest at?
The known deals of Parker Institute for Cancer Immunotherapy include Growth, Late-Stage and Seed rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
Who should I pitch at Parker Institute for Cancer Immunotherapy?
Both people on file at Parker Institute for Cancer Immunotherapy are listed as contacts for the firm, each with their own profile page.
How do I contact Parker Institute for Cancer Immunotherapy?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The 2 people attached to the firm have their own pages, each showing whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal